Clinical trial
Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal…
NCT02025725 · Evoke Pharma, Industry · Completed
Key facts
| NCT number | NCT02025725 |
|---|---|
| Title | Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis |
| Official title | Phase 3 Study of Intranasal Metoclopramide in Women With Symptomatic Diabetic Gastroparesis |
| Lead sponsor | Evoke Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Gastroparesis |
| Intervention type | Drug |
| Interventions | Metoclopramide Nasal Spray, Placebo Nasal Spray |
| Enrollment | 205 |
| Start date | Mar 27, 2014 |
| Primary completion | May 27, 2016 |
| Completion | Jun 27, 2016 |
| First posted | Jan 1, 2014 |
| Last update posted | Jul 7, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: